BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 2, Issue 12
  • This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Endoscopy
ISSN
1948-5190
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines for Clinical Practice
©2010 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Dec 16, 2010; 2(12): 388-396
Published online Dec 16, 2010. doi: 10.4253/wjge.v2.i12.388
Table 2 Noninvasive treatment of gastroesophageal reflux disease1
Lifestyle modification
Elevation of head of bed
Avoid eating within 3 h of bedtime
Avoid tobacco, alcohol, caffeine, fatty food, peppermint
Avoid harmful medications if possible, such as NSAIDs, beta blockers
Calcium-channel blockers, theophylline, potassium tablets, bisphosphonate
Medications
Antacids
Motility agents:
Metoclopramide, erythromycin, bethanechol, cisapride, GABA B-receptor agonists
H2 receptor antagonists:
Cimetidine, famotidine, nizatidine, ranitidine
PPI agents1:
Esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole, dexlansoprazole
GABA: Gamma-aminobutyric acid B-receptor agonist; NSAIDS: nonsteroidal anti-inflammatory drugs; H2: histamine2; PPI: proton pump inhibitor;
1Most often successful.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.